DSP Healthcare Fund - Growth - Direct Plan

Other Plans and Options
  • 1.01 %Nav, as on 02-04-2025

  • Previous Nav

  • Net Change on 02-04-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
DSP Healthcare Fund - Direct Plan - Growth 2.79 -11.02 14.71 20.71 30.02 24.79
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 14.71 20.71 30.02 0.63 2,950.74
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 11.20 19.01 28.72 0.91 7,637.04
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 18.83 23.40 31.94 1.11 4,611.47
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 18.20 23.58 30.56 0.97 3,312.89
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 16.16 18.96 29.95 0.52 2,441.13
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 14.33 20.23 28.34 0.74 1,103.99

Fund Holdings as on 28-February-2025

  • Suven Pharmaceuticals Limited

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • IPCA Laboratories Limited

  • Globus Medical Inc

  • Gland Pharma Limited

  • Illumina Inc

  • Apollo Hospitals Enterprise Limited

  • Laurus Labs Limited

  • Sai Life Sciences Limited

  • Alembic Pharmaceuticals Limited

  • Intuitive Surgical Inc

  • Vijaya Diagnostic Centre Limited

  • Kovai Medical Center and Hospital Limited

  • Pfizer Limited

  • Procter & Gamble Health Limited

  • Concord Biotech Limited

  • Indoco Remedies Limited

  • TREPS / Reverse Repo Investments

  • Unichem Laboratories Limited

  • Narayana Hrudayalaya Ltd.

  • ICICI Lombard General Insurance Company Limited

  • Abbott Laboratories

  • Emcure Pharmaceuticals Limited

  • Aarti Drugs Limited

  • Global X Funds - Global X Genomics & Biotechnology ETF

  • Alkem Laboratories Limited

  • Thyrocare Technologies Limited

  • Lupin Limited

  • Jupiter Life Line Hospitals Limited

  • Medplus Health Services Limited

  • Laxmi Dental Limited

  • Grail Inc

  • Net Receivables/Payables

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

  • Insurance

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

  • MFU

View More

About DSP Healthcare Fund

Scheme Analysis

DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹2,950.74 crore. DSP Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of DSP Healthcare Fund ended up ₹0.41(1.01%)yesterday to ₹40.745.

Among its top 3 holdings the fund has exposure to Suven Pharmaceuticals Limited, and

The DSP Healthcare Fund is managed by Chirag Dagli .

Fund House Contact

Mafatlal Centre, 10th Floor, Nariman Point, Mumbai - 400 021

+91 (22) 66578000
service@dspim.com
+91 (22) 66578181